Patents by Inventor Claus Friis Theisen

Claus Friis Theisen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Growth hormone crystals and a process for production of these GH-crystals
    Patent number: 6894023
    Abstract: A process for producing cation crystals of growth hormone or growth hormone derivatives, as well as growth hormone and growth hormone derivatives. The process of producing the growth hormone crystals includes the steps of (a) adding cations of inorganic or organic nature and an organic solvent or a mixture of inorganic solvents at a pH between 5.0 and 6.8 to a solution of growth hormone or derivatives. (b) growing growth hormone crystals at a temperature from about 0 to 30° C. and (c) isolating the cation crystals.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: May 17, 2005
    Assignee: Novo Nordisk A/S
    Inventors: Flemming Junker, Claus Friis Theisen
  • Growth hormone crystals and a process for production of these GH-crystals
    Patent number: 6117984
    Abstract: Divalent cation crystals of human growth factor (hGH) or derivatives thereof, and pharmaceutical preparations comprising divalent cation crystals of hGH. In specific embodiments, the divalent cation is Zn++ and the molar ration Zn++ and hGH is about 0.2 to about 10.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: September 12, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Flemming Junker, Claus Friis Theisen